Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, Q2 2026
-22,275
Period ended Jun 30, 2026
Change on a year earlier
-13.4%
-25,708 in Q2 2025
History
63 quarters
Since Q4 2008
Sources
62
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Retained earnings (accumulated deficit) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -22,275 | -13.4% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -24,650 | -9.2% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | -25,107 | -9.0% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | -23,800 | -6.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -25,708 | -5.2% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -27,140 | -2.6% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | -27,590 | +3.9% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | -25,530 | +2.2% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | -27,124 | +6.2% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -27,870 | +3.5% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | -26,549 | -7.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | -24,971 | -11.0% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | -25,540 | -9.6% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | -26,919 | -9.0% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | -28,622 | +16.3% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | -28,066 | +22.2% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | -28,252 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | -29,568 | +36.6% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | -24,600 | +14.9% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | -22,964 | +15.7% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2021 | Mar 31, 2021 | -21,639 | +1.2% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | -21,408 | +0.4% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | -19,851 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | -20,168 | +0.6% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | -21,378 | +7.5% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -21,330 | +18.7% | Form 10-K (filed 2020-02-12) ↗ |
| Q2 2019 | Jun 30, 2019 | -20,054 | +31.4% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | -19,895 | +38.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | -17,977 | +254.4% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | -15,987 | -1,001.2% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | -15,266 | -1,207.8% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | -14,387 | -6,274.7% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | -5,072 | +1,058.0% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,774 | +702.7% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,378 | -487.1% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 233 | -114.2% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | -438 | -79.0% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 221 | -109.4% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | -356 | -87.8% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | -1,638 | -59.6% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | -2,086 | -54.9% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | -2,352 | -49.9% | Form 10-Q (filed 2015-11-02) ↗ |
| Q2 2015 | Jun 30, 2015 | -2,912 | -46.8% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | -4,051 | -42.3% | Form 10-Q (filed 2015-04-27) ↗ |
| Q4 2014 | Dec 31, 2014 | -4,624 | -39.4% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | -4,698 | -40.1% | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | -5,476 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | -7,023 | -30.5% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | -7,634 | -26.8% | Form 10-K (filed 2014-02-24) ↗ |
| Q3 2013 | Sep 30, 2013 | -7,840 | -16.1% | Form 10-Q (filed 2013-10-29) ↗ |
| Q1 2013 | Mar 31, 2013 | -10,111 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | -10,423 | +16.9% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | -9,348 | – | Form 10-Q (filed 2012-11-06) ↗ |
| Q4 2011 | Dec 31, 2011 | -8,919 | +154.2% | Form 10-K (filed 2012-02-29) ↗ |
| Q1 2011 | Mar 31, 2011 | -2,383 | -50.9% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | -3,508 | -18.8% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | -3,394 | -16.0% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | -4,266 | -21.3% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | -4,852 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | -4,322 | -23.8% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | -4,042 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | -5,423 | – | Form 10-Q (filed 2009-08-10) ↗ |
| Q4 2008 | Dec 31, 2008 | -5,673 | – | Form 10-Q (filed 2009-08-10) ↗ |
Cite this data
StockData. (2026). Amgen Retained earnings (accumulated deficit) ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_re
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.